AstraZeneca is seeking a Vice President of Radioconjugate Development to lead the strategic development of novel radioconjugates in oncology. The ideal candidate will possess significant experience in drug development and demonstrate strong leadership and collaboration skills.
Base: $336,785.60 - $505,178.40; Bonus/Equity: Short-term incentive bonus and equity-based long-term incentive program; Benefits: 401(k) plan, paid vacation and holidays, paid leaves, health benefits
Must-have
Nice-to-have
Not specified